vs
Side-by-side financial comparison of Chaince Digital Holdings Inc. (CD) and Iterum Therapeutics plc (ITRM). Click either name above to swap in a different company.
Chaince Digital Holdings Inc. is the larger business by last-quarter revenue ($466.6K vs $390.0K, roughly 1.2× Iterum Therapeutics plc). Chaince Digital Holdings Inc. runs the higher net margin — -640.5% vs -2302.3%, a 1661.8% gap on every dollar of revenue.
Iterum Therapeutics plc is a clinical-stage biopharmaceutical company specializing in developing innovative anti-infective therapies to treat infections caused by multi-drug resistant bacteria. Its lead product candidate targets indications including community-acquired bacterial pneumonia and complicated urinary tract infections, addressing unmet medical needs across global healthcare markets.
CD vs ITRM — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $466.6K | $390.0K |
| Net Profit | $-3.0M | $-9.0M |
| Gross Margin | — | — |
| Operating Margin | -665.1% | -1982.3% |
| Net Margin | -640.5% | -2302.3% |
| Revenue YoY | — | — |
| Net Profit YoY | — | -47.3% |
| EPS (diluted) | $-0.05 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.2M | $11.0M |
| Total DebtLower is stronger | — | $20.0M |
| Stockholders' EquityBook value | $29.4M | $-7.4M |
| Total Assets | $36.6M | $32.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $11.0M | ||
| Q2 25 | $27.2M | — |
| Q3 25 | — | $20.0M | ||
| Q2 25 | — | — |
| Q3 25 | — | $-7.4M | ||
| Q2 25 | $29.4M | — |
| Q3 25 | — | $32.5M | ||
| Q2 25 | $36.6M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.3M | $-7.4M |
| Free Cash FlowOCF − Capex | — | $-7.5M |
| FCF MarginFCF / Revenue | — | -1912.6% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-7.4M | ||
| Q2 25 | $-1.3M | — |
| Q3 25 | — | $-7.5M | ||
| Q2 25 | — | — |
| Q3 25 | — | -1912.6% | ||
| Q2 25 | — | — |
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
